PT  - JOURNAL ARTICLE
AU  - Sergio Arredondo-Alonso
AU  - Janetta Top
AU  - Jukka Corander
AU  - Rob J L Willems
AU  - Anita C Schürch
TI  - Mode and dynamics of <em>vanA</em>-type vancomycin-resistance dissemination in Dutch hospitals
AID  - 10.1101/2020.07.21.20158808
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.21.20158808
4099  - http://medrxiv.org/content/early/2020/07/22/2020.07.21.20158808.short
4100  - http://medrxiv.org/content/early/2020/07/22/2020.07.21.20158808.full
AB  - Background Enterococcus faecium is a commensal of the gastrointestinal tract of animals and humans but also a causative agent of hospital-acquired infections. Resistance against glycopeptides and especially to vancomycin, a first-line antibiotic to treat infections with multidrug-resistant Gram-positive pathogens, has motivated the inclusion of E. faecium in the WHO global priority list. Vancomycin resistance can be conferred by the vanA gene cluster on the transposon Tn1546, which is frequently present in plasmids. The vanA gene cluster can be disseminated clonally but also horizontally either by plasmid dissemination or Tn1546 transposition between different genomic locations. Here, we reconstructed all nested genetic elements (clone, plasmid, transposon) to study how the dissemination of vanA-type vancomycin resistance occurred in Dutch hospitals (2012-2015).Methods We performed a retrospective study of the genomic epidemiology of 309 vancomycin-resistant E. faecium (VRE) isolates across 32 Dutch hospitals (2012-2015). Genomic information regarding clonality and Tn1546 characterisation was extracted using hierBAPS sequence clusters (SC) and TETyper, respectively. Plasmids were predicted using gplas in combination with a network approach based on shared k-mer content. This allowed determining all nested genomic elements (clone, plasmid and transposon) involved in the dissemination of the vanA gene cluster. Next, we conducted an “all vs. all” pairwise comparison between isolates sharinga potential epidemiological link to elucidate whether clonal, plasmid or Tn1546 spread accounted for the dissemination of vanA resistance.Results The 309 VRE isolates belonged to 18 different SCs of which SC13 (n = 102, 33%), SC17 (n = 52, 16.8%) and SC18 (n = 42, 13.6%) were predominant. We identified seven different plasmid types bearing the vanA gene cluster, four of which were highly similar (identity ∼99%, coverage∼84%) to previously described complete plasmid sequences. We estimated that clonal dissemination contributed most (∼45%) to the spread of vancomycin-resistance in Dutch hospitals, followed by Tn1546 mobilisation (∼12%) and plasmid dissemination (∼6%).Conclusions The dissemination of the vanA gene cluster in Dutch hospitals between 2012 and 2015 was dominated by clonal spread. However, we also identified outbreak settings with high frequencies of Tn1546 transposition and/or plasmid dissemination in which the spread of resistance was mainly driven by horizontal gene transfer (HGT). This study demonstrates the feasibility of distinguishing between modes of dissemination with short-read data and provides one of the first quantitative assessments to estimate the relative contribution of nested genomic elements in the dissemination of vanA-type vancomycin resistance cluster.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Joint Programming Initiative in Antimicrobial Resistance [JPIAMR Third call, STARCS, JPIAMR2016-AC16/00039 to S.A.-A. and R.J.L.W.]. It was also funded by the European Research Council [grant number 742158 to J.C.].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB is not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe raw paired-end reads of the 309 VRE isolates are available through the European Nucleotide Archive project PRJEB28495. The complete vanA plasmid sequences (n = 26) used to define the plasmid types (A-F) are also available through the NCBI Bioproject PRJEB28495 and the gitlab project https://gitlab.com/sirarredondo/vancomycin_dissemination The complete code used to generate the results present in this manuscript is provided in a RMarkdown document available through https://gitlab.com/sirarredondo/vancomycin_dissemination. https://gitlab.com/sirarredondo/vancomycin_dissemination WHOWorld Health OrganizationVREVancomycin resistant Enterococcus faeciumWGSWhole-genome sequencingHGTHorizontal gene transferAMRAntimicrobial resistanceSCSequencing clusterSNPSingle nucleotide polymorphismORFOpen reading frame